(Health-NewsWire.Net, May 10, 2019 ) Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications.
According to the International Diabetes Federation (IDF), in 2017, number of people with diabetes in North America was approximately 46 million which is expected to grow at 62 million in 2045. The increase in the disease prevalence is around 35% during the forecast period.
The emerging markets in the developing economies are expected to be the crucial factor offering better and lucrative growth opportunities for the major players to expand their business and geographic reach. The emerging markets in the developing countries are the major factor which are giving better opportunity for the major players to expand their business.
Request Sample with Future Advancement @ https://www.theinsightpartners.com/sample/TIPHE100001232/
F care systems
Asclepion Laser Technologies GmbH
Syneron Medical Ltd.
The global Artificial Pancreas Device System market by product was led by ablation devices segment. In 2017, the ablation devices segment held a largest market share of 67.1% of the Artificial Pancreas Device System market, by product. The segment is also expected to dominate the market during the year 2025, owing to the various technological advancements made by the market players during the recent years.
The Artificial Pancreas Device System market by treatment was segmented into, injection sclerotherapy, endovenous ablation, and surgical ligation. The endovenous ablation segment held the largest share of the market, by treatment. The segment is also expected to dominate during the year 2025, owing to the advantages offered by the technique that majorly include its minimally invasive nature over the traditional surgical methods, lesser complications, better and faster results and others.
End User Insights
The varicose veins end user devices market by end user was segmented into, hospitals, specialized clinics and ambulatory surgical centers. The hospitals segment held the largest share of the market, by end user with a share of around 61.9%.
The segment is also expected to dominate during the year 2025, owing to increasing number of hospitals and the availability of technologically advanced options as well as techniques for the treatment of varicose veins.
Read Comprehensive Overview of Report @ https://www.theinsightpartners.com/reports/artificial-pancreas-device-system-market
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
533, 5th Floor, Amanora Chambers,
Amanora Township, East Block,
Kharadi Road, Hadapsar, Pune-411028
The Insight Partners